Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer

Gastroenterology
Yuko MatsumotoT Chiba

Abstract

The DNA/RNA editing enzyme activation-induced cytidine deaminase (AID) is mutagenic and has been implicated in human tumorigenesis. Helicobacter pylori infection of gastric epithelial cells leads to aberrant expression of AID and somatic gene mutations. We investigated whether AID induces genetic aberrations at specific chromosomal loci that encode tumor-related proteins in gastric epithelial cells. Human gastric epithelial cell lines that express activated AID and gastric cells from AID transgenic mice were examined for DNA copy number changes and nucleotide alterations. Copy number aberrations in stomach cells of H pylori-infected mice and gastric tissues (normal and tumor) from H pylori-positive patients were also analyzed. In human gastric cells, aberrant AID activity induced copy number changes at various chromosomal loci. In AID-expressing cells and gastric mucosa of AID transgenic mice, point mutations and reductions in copy number were observed frequently in the tumor suppressor genes CDKN2A and CDKN2B. Oral infection of wild-type mice with H pylori reduced the copy number of the Cdkn2b-Cdkn2a locus, whereas no such changes were observed in the gastric mucosa of H pylori-infected AID-deficient mice. In human samples, th...Continue Reading

References

Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S Canning, T P Dryja
Nov 15, 2002·The New England Journal of Medicine·William C Hahn, Robert A Weinberg
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Ka-Fai ToJoseph J Y Sung
Feb 8, 2003·Current Opinion in Genetics & Development·Scott W Lowe, Charles J Sherr
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tomomitsu DoiTasuku Honjo
May 7, 2003·The Journal of Experimental Medicine·Il-mi OkazakiTasuku Honjo
Aug 19, 2004·Cell·Almudena R RamiroMichel C Nussenzweig
Jan 10, 2006·Nature·Almudena R RamiroMichel C Nussenzweig
Apr 8, 2006·The International Journal of Biochemistry & Cell Biology·Stuart J GallagherHelen Rizos
May 25, 2006·International Journal of Hematology·Kazuo Kinoshita, Taichiro Nonaka
Jun 27, 2006·Journal of Gastroenterology·Toshikazu UshijimaTakao Maekita
Aug 22, 2006·Nature Reviews. Molecular Cell Biology·Jesús Gil, Gordon Peters
Oct 24, 2006·Cell·William Y Kim, Norman E Sharpless
Oct 27, 2006·International Journal of Cancer. Journal International Du Cancer·Tadayuki KouTsutomu Chiba
Mar 31, 2007·Journal of Biochemistry and Molecular Biology·Toshikazu Ushijima
May 9, 2007·The Journal of Experimental Medicine·Niklas FeldhahnMarkus Müschen
Aug 29, 2007·The Journal of Experimental Medicine·Yair DorsettMichel C Nussenzweig
Nov 14, 2007·The Journal of Experimental Medicine·Alexander L KovalchukMichael Potter
Feb 29, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Junji KomoriTsutomu Chiba
Mar 11, 2008·The International Journal of Biochemistry & Cell Biology·Hiroyuki Marusawa
Sep 11, 2008·International Journal of Cancer. Journal International Du Cancer·Toshiyuki MorisawaTsutomu Chiba
Jan 24, 2009·International Journal of Cancer. Journal International Du Cancer·Georg W Bornkamm
Sep 17, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tsutomu Chiba, Hiroyuki Marusawa

❮ Previous
Next ❯

Citations

Sep 8, 2012·Immunologic Research·Carissa Dege, James Hagman
Aug 13, 2011·BMC Cancer·Glen M BorchertErik D Larson
Jul 30, 2015·Expert Review of Gastroenterology & Hepatology·Lei LiuJun Yu
Nov 28, 2012·Autoimmunity·Hong Zan, Paolo Casali
Jun 13, 2012·Seminars in Immunology·Alexandre Orthwein, Javier M Di Noia
Mar 29, 2011·Current Opinion in Immunology·Sébastien StorckClaude-Agnès Reynaud
Jul 8, 2015·European Journal of Immunology·Stefan Rebhandl, Roland Geisberger
Mar 15, 2016·The Journal of Clinical Investigation·Taichiro NonakaKazuo Kinoshita
Sep 4, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zheng-Hua FeiCong-Ying Xie
Sep 1, 2015·Gastroenterology Clinics of North America·Takahiro ShimizuTsutomu Chiba
Mar 13, 2014·Biochimica Et Biophysica Acta·Lotta Avesson, Guy Barry
Aug 19, 2016·Nature Reviews. Molecular Cell Biology·Cindrilla ChumduriThomas F Meyer
May 3, 2018·International Journal of Cancer. Journal International Du Cancer·Aya MizuguchiHiroyuki Marusawa
Jul 13, 2019·Journal of Cellular Biochemistry·Xi ChenEnjian Shen
Aug 19, 2015·EMBO Molecular Medicine·Arantxa Pérez-GarcíaAlmudena R Ramiro
May 21, 2013·Current Pathobiology Reports·Antonia R Sepulveda
Aug 6, 2011·Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·Takahiro Shimizu, Hiroyuki Marusawa
Sep 25, 2019·Journal of Translational Medicine·Theodoulakis Christofi, Apostolos Zaravinos
Jun 23, 2015·Oncoscience·Stefan RebhandlRoland Geisberger
May 23, 2018·Nature Chemical Biology·Xiaoting ShuChengqi Yi
Sep 9, 2011·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Tsutomu ChibaAtsushi Takai
Mar 15, 2018·Frontiers in Immunology·Emily C SheppardRichard Chahwan
Jul 3, 2018·Gastroenterology·Jason C Mills, Linda C Samuelson
May 1, 2021·Pathogens·Risa NakanishiHiroyuki Marusawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.